Lung Cancer Metastatic Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Non-small Cell Lung Cancer Metastatic
Sun Yat-sen University30 enrolled1 locationNCT06812871
Recruiting
Phase 2
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Non-small Cell Lung Cancer MetastaticEGFR G719XEGFR L861Q+1 more
Sun Yat-sen University23 enrolled1 locationNCT06517953